Azapeptide analogues of the growth hormone releasing peptide 6 as cluster of differentiation 36 receptor ligands with reduced affinity for the growth hormone secretagogue receptor 1a

Journal of Medicinal Chemistry

Volumn 55, Issue 14, 2012, Pages 6502-6511

  Proulx, Caroline ^a   Picard, Émilie ^a   Boeglin, Damien ^a   Pohankova, Petra ^a   Chemtob, Sylvain ^a   Ong, Huy ^a   Lubell, William D ^a  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CD36 ANTIGEN; EP 80317; GHRELIN RECEPTOR; HEXARELIN; HISTIDYL DEXTRO TRYPTOPHYLALANYLTRYPTOPHYL DEXTRO PHENYLALANYLLYSINAMIDE; HISTIDYL DEXTRO TRYPTOPHYLALANYLTRYPTOPHYL DEXTRO PHENYLALANYLLYSINAMIDE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ANTIANGIOGENIC ACTIVITY; ARTICLE; CHOROID; COMBINATORIAL CHEMISTRY; CONTROLLED STUDY; DRUG RECEPTOR BINDING; DRUG SYNTHESIS; EXPLANT; MOUSE; NONHUMAN; PEPTIDE SYNTHESIS; RAT; RECEPTOR AFFINITY;

AMINO ACID SEQUENCE; ANGIOGENESIS INHIBITORS; ANIMALS; ANTIGENS, CD36; AZA COMPOUNDS; CELL LINE; INHIBITORY CONCENTRATION 50; LIGANDS; OLIGOPEPTIDES; PROTEIN BINDING; RATS; RECEPTORS, GHRELIN;

EID: 84864186354     PISSN: 00222623     EISSN: 15204804     Source Type: Journal    
DOI: 10.1021/jm300557t     Document Type: Article

References (48)

1. Momany, F.; Bowers, C. Y.; Reynolds, G. A.; Hong, A.; Newlander, K. Conformational Energy Studies and in Vitro and in Vivo Activity Data on Growth Hormone-Releasing Peptides Endocrinology 1984, 114 (5) 1531-1536
2. Popovic, V.; Damjanovic, S.; Micic, D.; Djurovic, M.; Dieguez, C.; Casanueva, F. F. Blocked Growth Hormone-Releasing Peptide (GHRP-6)-Induced GH Secretion and Absence of the Synergic Action of GHRP-6 Plus GH-Releasing Hormone in Patients with Hypothalamopituitary Disconnection: Evidence That GHRP-6 Main Action Is Exerted at the Hypothalamic Level J. Clin. Endocrinol. Metab. 1995, 80 (3) 942-947
3. Ghigo, E.; Arvat, E.; Gianotti, L.; Imbimbo, B. P.; Lenaerts, V.; Deghenghi, R.; Camanni, F. Growth Hormone-Releasing Activity of Hexarelin, a New Synthetic Hexapeptide, after Intravenous, Subcutaneous, Intranasal, and Oral Administration in Man J. Clin. Endocrinol. Metab. 1994, 78 (3) 693-698
4. Imbimbo, B. P.; Mant, T.; Edwards, M.; Amin, D.; Dalton, N.; Boutignon, E.; Lenaerts, V.; Wiithrich, P.; Deghenghi, R. Growth hormone-releasing activity of hexarelin in humans. A dose-response study Eur. J. Clin. Pharmacol. 1994, 46, 421-425
5. Cordido, F.; Peñalva, A.; Dieguez, C.; Casanueva, F. F. Massive growth hormone (GH) discharge in obese subjects after the combined administration of GH-releasing hormone and GHRP-6: evidence for a marked somatotroph secretory capability in obesity J. Clin. Endocrinol. Metab. 1993, 76, 819-23
6. Frutos, M. G-S.; Cacicedo, L.; Fernandez, C.; Vicent, D.; Velasco, B.; Zapatero, H.; Sanchez-Franco, F. Insights into a role of GH secretagogues in reversing the age-related decline in the GH/IGF-1 axis Am. J. Physiol. Endocrinol. Metab. 2007, 293, E1140-E1152
7. Marleau, S.; Harb, D.; Bujold, K.; Avallone, R.; Iken, K.; Wang, Y.; Demers, A.; Sirois, M. G.; Febbraio, M.; Silverstein, R. L.; Tremblay, A.; Ong, H. EP 80317, a ligand of the CD36 scavenger receptor, protects apolipoprotein E-deficient mice from developing atherosclerotic lesions Fed. Am. Soc. Exp. Biol. J. 2005, 19, 1869-1871
8. Bodart, V.; Bouchard, J. F.; McNicoll, N.; Escher, E.; Carriere, P.; Ghigo, E.; Sejlitz, T.; Sirois, M. G. Identification and characterization of a new growth hormone-releasing peptide receptor in the heart Circ. Res. 1999, 85, 796-802
9. Endemann, G.; Stanton, L. W.; Madden, K. S.; Bryant, C. M.; White, R. T.; Protter, A. A. CD36 is a receptor for oxidized low density lipoprotein J. Biol. Chem. 1993, 268, 11811-11816
10. Febbraio, M.; Podrez, E. A.; Smith, J. D.; Hajjar, D. P.; Hazen, S. T.; Hoff, H. F.; Sharma, K.; Silverstein1, R. L Targeted disruption of the class B scavenger receptor CD36 protects against atherosclerotic lesion development in mice J. Clin. Invest. 2000, 105, 1049-1056
11. Demers, A.; McNicoll, N.; Febbraio, M.; Servant, M.; Marleau, S.; Silverstein, R.; Ong, H. Identification of the growth hormone-releasing peptide binding site in CD36: a photoaffinity cross-linking study Biochem. J. 2004, 382, 417-424
12. Febbraio, M.; Silverstein, R. L. CD36: Implications in Cardiovascular Disease Int. J. Biochem. Cell Biol. 2007, 39 (11) 2012-2030
13. Jiménez, B.; Volpert, O. V.; Crawford, S. E.; Febbraio, M.; Silverstein, R. L.; Bouck, N. Signals leading to apoptosis-dependent inhibition of neovascularization by thrombospondin-1 Nature Med. 2000, 6, 41-48
14. Sun, J.; Hopkins, B. D.; Tsujikawa, K.; Perruzi, C.; Adini, I.; Swerlick, R.; Bornstein, P.; Lawler, J.; Benjamin, L. E. Thrombospondin-1 modulates VEGF-A mediated Akt signaling and capillary survival in the developing retina Am. J. Physiol. 2009, 296, H1344-H1351
15. Proulx, C.; Sabatino, D.; Hopewell, R.; Spiegel, J.; García Ramos, Y.; Lubell, W. D. Azapeptides and their therapeutic potential Future Med. Chem. 2011, 3 (9) 1139-1164
16. Reynolds, C. H.; Hormann, R. E. Theoretical study of the structure and rotational flexibility of diacylhydrazines: implications for the structure of nonsteroidal ecdysone agonists and azapeptides J. Am. Chem. Soc. 1996, 118, 9395-9401
17. Lee, H.-J.; Song, J.-W.; Choi, Y.-S.; Park, H.-M.; Lee, K.-B. A theoretical study of conformational properties of N -methyl azapeptide derivatives J. Am. Chem. Soc. 2002, 124, 11881-11893
18. André, F.; Boussard, G.; Bayeul, D.; Didierjean, C.; Aubry, A.; Marraud, M.; Aza-peptides., I. I. X-Ray structures of aza-alanine and aza-asparagine-containing peptides J. Peptide Res. 1997, 49, 556-562
19. André, F.; Vicherat, A.; Boussard, G.; Aubry, A.; Marraud, M. Aza-peptides. III. Experimental structural analysis of aza-alanine and aza-asparagine-containing peptides J. Peptide Res. 1997, 50, 372-381
20. Gassman, J. M.; Magrath, J. An active-site titrant for chymotrypsin, and evidence that azapeptide esters are less susceptible to nucleophilic attack than ordinary esters Bioorg. Med. Chem. Lett. 1996, 6 (15) 1771-1774
21. Boeglin, D.; Lubell, W. D. Aza-amino acid scanning of secondary structure suited for solid-phase peptide synthesis with Fmoc chemistry and aza-amino acids with heteroatomic side chains J. Comb. Chem. 2005, 7, 864-878
22. Dutta, A. S.; Furr, B. J. A.; Giles, M. B.; Valcaccia, B. Synthesis and biological activity of highly active α-aza analogues of luliberin J. Med. Chem. 1978, 21 (10) 1018-1024
23. Patchett, A. A.; Harris, E.; Tristram, E. W.; Wyvratt, M. J.; Wu, M. T.; Taub, D.; Peterson, E. R.; Ikeler, T. J.; ten Broeke, J.; Payne, L. G.; Ondeyka, D. L.; Thorsett, E. D.; Greenlee, W. J.; Lohr, N. S.; Hoffsommer, R. D.; Joshua, H.; Ruyle, W. V.; Rothrock, J. W.; Aster, S. D.; Maycock, A. L.; Robinson, F. M.; Hirschmann, R.; Sweet, C. S.; Ulm, E. H.; Gross, D. M.; Vassil, T. C.; Stone, C. A. A new class of angiotensin-converting enzyme inhibitors Nature 1980, 288, 280-283
24. Baggio, R.; Shi, Y.-Q.; Wu, Y.-Q.; Abeles, R. H. From Poor Substrates to Good Inhibitors: Design of Inhibitors for Serine and Thiol Proteases Biochemistry 1996, 35 (11) 3351-3353
25. Magrath, J.; Abeles, R. H. Cysteine Protease Inhibition by Azapeptide Esters J. Med. Chem. 1992, 35, 4279-4283
26. Boeglin, D.; Hamdan, F. F.; Melendez, R. E.; Cluzeau, J.; Laperriere, A.; Héroux, M.; Bouvier, M.; Lubell, W. D. Calcitonin gene-related peptide analogues with aza and indolizidinone amino acid residues reveal conformational requirements for antagonist activity at the human calcitonin gene-related peptide 1 receptor J. Med. Chem. 2007, 50, 1401-1408
27. Ekici, Ö. D.; Götz, M. G.; James, K. E.; Li, Z. Z.; Rukamp, B. J.; Asgian, J. L.; Caffrey, C. R.; Hansell, E.; Dvorák, J.; McKerrow, J. H.; Potempa, J.; Travis, J.; Mikolajczyk, J.; Salvesen, G. S.; Powers, J. C. Aza-Peptide Michael Acceptors: A New Class of Inhibitors Specific for Caspases and Other Clan CD Cysteine Proteases J. Med. Chem. 2004, 47, 1889-1892
28. Sabatino, D.; Proulx, C.; Klocek, S.; Bourguet, C. B.; Boeglin, D.; Ong, H.; Lubell, W. D. Exploring Side-Chain Diversity by Submonomer Solid-Phase Aza-Peptide Synthesis Org. Lett. 2009, 11, 3650-3653
29. Sabatino, D.; Proulx, C.; Pohankova, P.; Ong, H.; Lubell, W. D. Structure-Activity Relationships of GHRP-6 Azapeptide Ligands of the CD36 Scavenger Receptor by Solid-Phase Submonomer Azapeptide Synthesis J. Am. Chem. Soc. 2011, 133, 12493-12506
30. Kobayashi, S.; Fukuta, M.; Kontani, H.; Yanagita, S.; Kimura, I. A Quantitative Assay for Angiogenesis of Cultured Choroidal Tissues in Streptozotocin-Diabetic Wistar and Spontaneously Diabetic GK Rats Jpn. J. Pharmacol. 1998, 78, 471-478
31. 1-Dipeptides in Peptide Synthesis J. Am. Chem. Soc. 2004, 126 (21) 6759-6764
32. Proulx, C.; Lubell, W. D. Solid-Phase Synthesis of Aza-Proline Analogs of GHRP-6. In Peptides: Breaking Away. Proceedings of the 21st American Peptide Symposium; Lebl, M., Ed.; Prompt Scientific Publishing: San Diego, CA, 2009; pp 56-57.
33. Freeman, N. S.; Tal-Gan, Y.; Klein, S.; Levitzki, A.; Gilon, C. Microwave-Assisted Solid-Phase Aza-peptide Synthesis: Aza Scan of a PKB/Akt Inhibitor Using Aza-arginine and Aza-proline Precursors J. Org. Chem. 2011, 76, 3078-3085
34. Lubell, W. D.; Blankenship, J. W.; Fridkin, G.; Kaul, R. Peptides. Science of Synthesis 21.11, Chemistry of Amides; Thieme: Stuttgart, 2005; pp 713-809.
35. 2 Chem. Biol. Drug Des. 2006, 67, 275-283
36. Nexus Biosystems; http://www.irori.com/.
37. Demange, L.; Boeglin, D.; Moulin, A.; Mousseaux, D.; Ryan, J.; Bergé, G.; Gagne, D.; Heitz, A.; Perrissoud, D.; Locatelli, V.; Torsello, T.; Galleyrand, J.-C.; Fehrentz, J.-A.; Martinez, J. Synthesis and Pharmacological in Vitro and in Vivo Evaluations of Novel Triazole Derivatives as Ligands of the Ghrelin Receptor J. Med. Chem. 2007, 50, 1939-1957
38. Bodart, V.; Febbraio, M.; Demers, A.; McNicoll, N.; Pohankova, P.; Perreault, A.; Sejlitz, T.; Escher, E.; Silverstein, R. L.; Lamontagne, D.; Ong, H. CD36 mediates the cardiovascular action of Growth Hormone-Releasing Peptides in the heart Circ. Res. 2002, 90, 844-849
39. Didierjean, C.; Del Duca, V.; Benedetti, E.; Aubry, A.; Zouikri, M.; Marraud, M.; Boussard, G. X-ray structures of aza-proline-containing peptides J. Pept. Res. 1997, 50, 451-457
40. Zouikri, Vicherat, A.; Aubry, A.; Marraud, M.; Boussard, G. Azaproline as a β-turn-inducer residue opposed to proline J. Pept. Res. 1998, 52, 19-26
41. Lecoq, A.; Boussard, G.; Marraud, M.; Aubry, A. Crystal state conformation of three azapeptides containing the azaproline residue, a β-turn regulator Biopolymers 1993, 33, 1051-1059
42. Lecoq, A.; Boussard, G.; Marraud, M. The couple Pro/AzaPro: a means of β-turn formation control synthesis and conformation of two aza-pro-containing dipeptides Tetrahedron Lett. 1992, 33 (36) 5209-5212
43. Sun, J.; Hopkins, B. D.; Tsujikawa, K.; Perruzzi, C.; Adini, I.; Swerlick, R.; Bornstein, P.; Lawler, J.; Benjamin, L. E. Thrombospondin-1 modulates VEGF-A-mediated Akt signaling and capillary survival in the developing retina Am. J. Physiol. Heart Circ. Physiol. 2009, 296 (5) H1344-51
44. Bush, C. A.; Sarkar, S. K.; Kopple, K. D. Circular dichroism of β turns in peptides and proteins Biochemistry 1978, 17, 4951-4954
45. Gibson, C.; Goodman, S. L.; Hahn, D.; Hölzemann, G.; Kessler, H. Novel solid-phase synthesis of azapeptides and azapeptoides via Fmoc-strategy and its application in the synthesis of RGD-mimetics J. Org. Chem. 1999, 64, 7388-7394
46. Carpino, L. A.; Han, J. Y. The 9-Fluorenylmethoxycarbonyl Amino-Protecting Group J. Org. Chem. 1972, 37, 3404-3409
47. Zhang, W.-J.; Berglund, A.; Kao, J. L.-F.; Couty, J.-P.; Gershengorn, M. C.; Marshall, G. R. Impact of Azaproline on Amide Cis-Trans Isomerism: Conformational Analyses and NMR Studies of Model Peptides Including TRH Analogues J. Am. Chem. Soc. 2003, 125, 1221-1235
48. Harigaya, S.; Schwartz, A. Rate of calcium binding and uptake in normal animal and failing human cardiac muscle: membrane vesicles (relaxing system) and mitochondria Circ. Res. 1969, 25, 781-794